By working with more therapeutic candidates of a wider variety of biopharmaceutical modalities you increase your chances of developing the next blockbuster drug. You also increase your chances of running into candidates that present unique analytical challenges.
In this webinar Christian Milbrandt from J&J/Janssen presents a non-platform method development approach using a 96-well-plate and capillary electrophoresis–sodium dodecyl sulfate (CE-SDS) to provide high-throughput analysis of challenging biopharmaceutical drug candidates.
Key learning objectives:
Development of non-platform methods for analysis of complex modalities
96-well-plate format for high throughput CE-SDS
Flexible software and optimization tips for CE-SDS
Christian Milbrandt Research & Development J&J Janssen
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK